Literature DB >> 1958099

Pneumococcal septic arthritis after splenectomy in Felty's syndrome.

M Brzeski1, L Smart, D Baird, R Jackson, R Sturrock.   

Abstract

A patient with Felty's syndrome who developed bilateral knee septic arthritis and septicaemia due to Streptococcus pneumoniae is described. She had had a previous splenectomy for symptomatic thrombocytopenia, having received pneumococcal vaccine before the operation. Measurement of antibody to the 23 vaccine serotypes showed protective concentrations before infection to just two. The infecting serotype was not represented in the vaccine, but a vigorous antibody response to this serotype occurred. The patient also developed glomerulonephritis due to immune complex deposition.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958099      PMCID: PMC1004541          DOI: 10.1136/ard.50.10.724

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  Acute nephritis and pulmonary alveolitis following pneumococcal pneumonia.

Authors:  W D Kaehny; T Ozawa; M I Schwarz; R E Stanford; P F Kohler; R M McIntosh
Journal:  Arch Intern Med       Date:  1978-05

2.  Felty's syndrome: long-term follow-up after splenectomy.

Authors:  R A Moore; C M Brunner; W R Sandusky; B S Leavell
Journal:  Ann Intern Med       Date:  1971-09       Impact factor: 25.391

3.  Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine.

Authors:  S W Hosea; C G Burch; E J Brown; R A Berg; M M Frank
Journal:  Lancet       Date:  1981-04-11       Impact factor: 79.321

4.  Alternative C3 pathway activiation in pneumococcal glomerulonephritis.

Authors:  L R Hyman; E H Jenis; G S Hill; S W Zimmerman; P M Burkholder
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

Review 5.  Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

Authors:  J B Robbins; R Austrian; C J Lee; S C Rastogi; G Schiffman; J Henrichsen; P H Mäkelä; C V Broome; R R Facklam; R H Tiesjema
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

Review 6.  Postsplenectomy infection.

Authors:  E L Francke; H C Neu
Journal:  Surg Clin North Am       Date:  1981-02       Impact factor: 2.741

Review 7.  Pneumococcal endocarditis in adult patients. A report of five cases and review of the literature.

Authors:  G A Bruyn; J Thompson; J W Van der Meer
Journal:  Q J Med       Date:  1990-01

8.  Immune response to acute otitis media in children. I. Serotypes isolated and serum and middle ear fluid antibody in pneumococcal otitis media.

Authors:  J L Sloyer; V M Howie; J H Ploussard; A J Ammann; R Austrian; R B Johnston
Journal:  Infect Immun       Date:  1974-06       Impact factor: 3.441

9.  Long-term outcome in Felty's syndrome.

Authors:  C Thorne; M B Urowitz
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

10.  Splenectomy for Felty's syndrome. Clinicopathological study of 27 patients.

Authors:  J Laszlo; R Jones; H R Silberman; P M Banks
Journal:  Arch Intern Med       Date:  1978-04
View more
  4 in total

1.  Destructive pneumococcal septic arthritis in end-stage renal disease.

Authors:  I F Ciernik; J C Gerster; P Burckhardt
Journal:  Clin Rheumatol       Date:  1997-09       Impact factor: 2.980

Review 2.  Early postsplenectomy arthritis caused by penicillin-resistant Streptococcus pneumoniae.

Authors:  M Merle-Melet; J M Tortuyaux; S Condette; P Maurer; C Lion; P Boissel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-02       Impact factor: 3.267

3.  Bilateral, simultaneous pneumococcal septic arthritis of the knees: a normal immune system, an unknown source.

Authors:  Thomas Ian Whitehead-Clarke; Raj Singavarapu; Abhinav Gulihar; Krissen Chettiar
Journal:  BMJ Case Rep       Date:  2016-05-05

4.  Streptococcus pneumoniae causing septic arthritis with shock and revealing multiple myeloma.

Authors:  Moussa Albert Riachy
Journal:  BMJ Case Rep       Date:  2011-05-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.